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S-Antigen is a major soluble protein of the retina and pineal. It is capable of inducing experimental autoim- 
mune uveitis (EAU) in laboratory animals and also seems to play an important role in the visual cycle. 
The results of partial cDNA sequence analysis reveal interesting homologies with a-transducin, a GTP-bind- 
ing protein of retina and other purine nucIeotide-binding proteins. In particular S-antigen shows over 50% 
identity to the proposed pertussis toxin ADP-~~sylation site of a-transducin. It also contains the Gly-X-X- 
X-X-Giy-Lys pattern common to phosphoryl binding sites. A possible relationship between S-antigen and 
purine nucleotide-binding proteins is discussed. There is also evidence for a repetitious /I-structure in the 
C-terminal half of S-antigen, with a monoclonal antibody epitope in a helical region at the C-terminus. 
{Bovine retina) S-Antigen Uveitb eDNA seqwnce a-Transducin ADP-ribosylation 
1. INTRODUCTION 
S-Antigen is a soluble protein of the retina and 
pineal [l]. Its molecular mass by laser-light scatter- 
ing and ultracentrifugation is 42-44 kDa [2] 
(although SDS-PAGE gives an estimate of 
50 kDa). It seems to exist in immunochemically 
conserved forms from molluscs to mammals 131. 
Recently, it has been shown that S-antigen binds 
photoexcited-phosphorylat~ rhodopsin [4] and 
may therefore play an important role in the visual 
cycle. In light-adapted bovine retinas, S-antigen 
and rhodopsin have been detected in quantities ap- 
proaching a 1: 1 molar ratio [fi]. 
The protein is also highly antigenic and anti-S- 
antigen activities have been detected in some pa- 
tients suffering from the inflammatory condition 
uveitis [6]. Furthermore, purified S-antigen is able 
to induce similar symptoms in various laboratory 
animals in the condition known as experimental 
auto~mune uveitis (EAU) [1,7,8]. In spite of the 
interest in this molecule no sequence data have yet 
been presented. Here we describe the determina- 
tion of the sequence of the C-terminal 239 residues 
of bovine S-antigen by cDNA sequencing. Ex- 
amination of the predicted amino-acid sequence 
suggests hat S-antigen has an intently r~etitious 
structure. It has also allowed the position of an 
anti-S-antigen monoclonal antibody epitope to be 
predicted. Sequence comparisons have revealed 
some interesting regions of homology with IY- 
transducin and other purine nucleotide-binding 
proteins, the functional family which includes G- 
proteins, elongation factors and ras proteins 
among others. 
2. MATERIALS AND METHODS 
2.1. Isolation of cDNA clones 
cDNA clones were isolated from two bovine 
retina libraries as described elsewhere (Craft et al., 
submitted). Three overlapping cDNAs of approx. 
420,220 and 150 bp were isolated by immunoreac- 
tivity from the Agtll [9] library of Dr Oprian 
(MIT). The 420 bp cDNA was used to screen a 
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larger, 880 bp cDNA from the hgtl0 library of Dr 
Nathans (Stanford) [ 101 by hybridization. 
The EcoRI fragment cDNA inserts were 
subcloned into the EcoRI site of Ml3 mp19 [Ill 
using reagents from Bethesda Research Lab- 
oratories (Gaithersburg, MD). The inserts were 
also further digested using SstI, BarnHI and BgflI. 
These fragments were subcloned into Ml3 mp18 
and mp19 [ll] in order to obtain both strands of 
each fragment in the sequencing vector. The 
recombinant phages were then transfected into E. 
coli JMlOl [12]. 
Sequences were obtained by the dideoxy chain 
termination method of Sanger et al. [13], modified 
for 35S-ATP (Amersham, Arlington Heights, IL) 
essentially as described in the BRL Ml3 clon- 
ing/dideoxy sequencing manual. Enzymes were 
obtained from BRL and International Bio- 
technologies (New Haven, CT). Nucleotides, both 
deoxy- and dideoxy- were obtained from 
Pharmacia-PL Biochemicals (Piscataway, NY). 
Sequences were run on 8% bisacrylamide urea gels 
which were dried for autoradiography by the pro- 
cedure of Vasil [14]. Most sequences were 
generated by using the universal Ml3 15-mer 
primer, sequencing across internal restriction en- 
zyme sites or across the EcoRI sites resulting from 
the use of linkers in the cloning procedure. Some 
confi~atory overlapping sequences (fig. 1) were 
later obtained by the use of synthetic 15mer 
primers designed from the determined sequence 
and synthesized by OCS Labs (Denton, TX). 
3. RESULTS AND DISCUSSION 
The strategy for the determination of the 
nucleotide sequence of the complete 880 bp frag- 
ment, together with the overlapping 420, 220 and 
150 bp fragments is shown in fig. 1. Each arrow 
represents at least two and up to six different Ml3 
subclones, except for that reading in from the ex- 
treme 3 ‘-end of the 880 bp fragment. Only one 
Ml3 clone for this strand was obtained. It is possi- 
ble that some part of the cDNA insert in that sense 
compromises the viability of the Ml3 vector. 
Similarly, a lo-fold excess of Ml3 clones for one 
strand of the 420 bp EcoRI-EcoRI fragment was 
observed compared to the reverse strand. To con- 
firm certain parts of the sequence, specific, 15mer 
oligonucleotide primers were designed to allow se- 
quence initiation close to the desired region. Se- 
quences were read by compiling data from suc- 
cessively longer gel runs of the same sequencing 
reaction. 
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Fig-l. Determination of the nucleotide sequence of the 880 bp and smaller cDNAs for bovine S-antigen. Restriction 
sites are shown boxed: BH, BumHI; BG, BgfII; S, MI. A, B, C indicate the 5 I- and 3’-ends of the 420,220 and 150 bp 
fragments, respectively. Arrows show the origin and extents of sequences from different classes of Mi3 subclones. 
Sl-S6 mark the positions of synthetic IJ-mer primers used for sequence confirmation. (--) Equivalent positions of 
peptide sequences determined by amino-acid sequencing (Dietzschold et al., in preparation). 
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One long open reading frame (fig.2) terminating was observed in the nucleotide sequence. 
after 239 predicted residues was observed after The predicted amino-acid sequence was then 
computer translation of the nucleotide sequence. aligned with the partial peptide sequences obtained 
This open frame matched that predicted for the independently by Dietzschold et al. (in prepara- 
hgtll clones which were detected as the result of tion) (figs 1 and 2), confirming the identity of the 
fusion protein expression [9]. The size of the cDNA clones. There were no matches between the 
predicted polypeptide (26822 Da) corresponds to peptide sequences and any translated reading 
about two-thirds of that expected for a 42 kDa frame of the nucleotide sequence 3 ‘- to the first 
protein. No poly(A) tail or polyadenylation signal stop codon. 
LysLysSerSerVolAr LeuLeuIleAr 
###########P########### 
100 110 120 130 140 150 160 170 180 
TTCTTCATGTCGGACMGCCCCTGCCCCTCGCCCTCGCCGTCTCGCTCAGCMAGAGATCTATTACCACGGGGMCCCATTCCTGTGACCGTGCCC 
190 200 210 220 230 240 250 260 270 
GTGACCMCAGCACAGAGMGACAGTGMGMGATTlUAGTGCTAGTGGAGCMGTGACCMCGTGGTTCTCTACTCGAGTGATTATTAC 
ThrAsnSerThrGluLyaThrVolLy~Ly~Il~LysVoiLeuVolGluGlnVolThrAsnVolVolLeuTyr 
###### - #############################f##f###f##f##### 
280 290 300 310 320 330 340 350 360 
ATCMGACGGTGGCTGCCGAGGMGCACAGGAAMAGTGCCGCAGCTCGCTGACCMGACGCTGACGCTGGTGCCCTTGCTGGCC 
9Rm 
-~ThrVolAloAloGluGluAloGlnGluLy~VolProProAsnSerS~rLeuThrLyaThrLeuThrLeuVolProLeuLeuAlo 
ffff ########- ################################# 
370 380 390 400 410 420 430 440 450 
MCMCCGTGAGAGMGGGGCATCGCCCTGGATGGGAAMTGGAGGGA 
AsnAsnArgGluArgArgGlyIleAloLeuAspGlyLys SerThrIlelleLysGluGly 
#######f##X###f### 
460 470 480 490 500 510 520 530 540 
ATAGACMGACCGTCATGGGGATCCTGGTGTCTTACCAGATCMGGTGMGCTCACGGTGTCAGGCCTTCTGGGAGAGCTCACATCCAGT 
I IeAspLysThrVol 
I## ###### 
ThrVolSerGlyLeuLeuGIyGluLeuThrSerSer 
######################## 
550 560 570 580 590 600 610 620 630 
GAAGTGGCCACTGAGGTGCCGTTCCGCCTCATGCATCCCCAGCCAGAGGACCCAGATACCGCCAAGG~GTTTTCAGGATGAAAATTTT 
GluVolAloThrGluVolProPheAr .-. . . 
filXltt~~flltilllrfi~~~~~~~ 
IuSerPheGlnAspGluAsnPhe 
#Y######f 
640 650 660 670 680 690 700 710 720 
GTTTTTGAGGAGTTTGCTCGCCAAAATCTGAAAGATGCAGGAGMTATAAGGMGAG~GACAGACCAGGAGGCGGCTATGGATGAGTGA 
VolPheGIuGluPheAIoArgGInAsnLeuLys~LysGIuGIuLysThrAspGInGIuAIoAIoMetAspGIuTer 
30 
60 
90 
120 
150 
180 
210 
240 
730 740 750 760 770 780 790 800 810 
AGAGGCGACTCAGGAGGAGTGGG~TGCCTAGATGCTGCTCAGAGGGCCTTGTACAGGGACGTGATGGTGGAGACCCTCAGGAACCTAGT 
820 830 840 850 860 870 880 
CTCCTTGGATATCTCTCATATACTTGTGATCGAAGAATTACAACTAAATG AAAAAACTGACAGAGGAGAGAATTC 
Fig.2. The sequence of the 880 bp cDNA clone for bovine S-antigen. The upper line shows the nucleotide sequence. 
The lower line shows the predicted amino-acid sequence with the positions of peptides determined by amino-acid 
sequencing (Dietzschold et al., in preparation) indicated by reverse tone. Regions of secondary structure predicted by 
the method of Garnier et al. [16] are shown: (#) extended (8) conformation, (a) coil or turn, (To) helical (cu) 
conformation. Nucleotide numbers are given horizontally, predicted amino acids are numbered vertically. 
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3.1. Secondary structure 
The algorithms of Chou and Fasman [15] and 
Garnier et al. [ 161, as implemented in the package 
IDEAS [ 171, were used to predict secondary struc- 
ture for the predicted 239 C-terminal residues of S- 
antigen. For the method of Garnier et al., in the 
absence of circular dichroism data or other 
estimates of secondary structure a range of deci- 
sion constants DCH (75-158) and DCE (88-50) 
were used. The results, summarized in fig. 1, all in- 
dicated a predominantly extended conformation 
(&sheet conformation) interspersed with short 
regions of turn, containing little predicted helical 
conformation. In contrast, the C-terminal 27 
residues were predicted to have helical structure 
with a central break of turn or coil. 
It was then observed that several sections of the 
sequence exhibiting the pattern of extended con- 
formation followed by turn or coil had some se- 
quence similarity. The most striking resemblance is 
between residues 2-30, and residues 178-206 
which have 11 identical residues (34% identity) 
allowing for gaps (fig.fa). These two segments 
have interesting positions in the S-antigen se- 
quence. If a total length of about 380 residues is 
assumed for a 42 kDa protein and if the C- 
terminal helical region of about 30 residues is ig- 
nored, it is apparent hat residues 2-30 lie at the C- 
terminal end of the first half of the molecule while 
residues 178-206 lie at the equivalent position in 
the second half. This would be consistent with a 
a-fold repeat in the protein sequence. 
With weaker agreement other segments (41-66, 
85-105, 106-139, 142-163), can also be fitted to 
this general alignment of similar secondary struc- 
tures with limited sequence homology (fig.3a). It is 
possible that S-antigen has an internally repetitious 
structure, at least at the level of a 2-fold repeat, of 
the kind that has been observed for other groups of 
proteins, such as fl,y-crystallins [ 18,191 and acid 
proteases [20] and is often thought to be the result 
of gene multiplication and fusion. 
############# 99889 
A C B 
-- - - -- -- -2- 
EEFAiQNLLDAGEYiEEiTDQEAAMDE 
%%%%%%% @Q@Gt%%%%%%%%%%%%% 
ODE B --FAii EY 206-226 0 v AVTDIIIK LF 326-350 
2-30 
178-206 
142-163 
41-66 
85-105 
106-138 
SA 
AT 
(a) 
(b) 
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Fig.3. (a) Comparison of the amino-acid sequences of S-antigen peptides which have similar predicted secondary 
structures. Identical residues are boxed. (#) Predicted extended structure, (@) predicted coil or turn in the regions of 
approximate consensus in predicted conformation [15,16]. Single-letter amino-acid code is used. (b) C-terminal peptide 
of bovine S-antigen. Predicted secondary structures are shown: (Vo) predicted helix, (@) coil or turn. (+ , -) Indicate 
the charge on each residue. A, B, C mark the C-termini of the peptide products of the 420, 220 and 150 bp cDNA 
fragments. (c) Comparison of residues 206-226 of the S-antigen (SA) sequence with residues 326-350 of cy-transducin 
(AT) [26,27]. Identical residues are boxed. Closely conserved variations are indicated by - . The region identified with 
pertussis toxin ADP-ribosylation [26-281 is underlined with dots. 
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In contrast to the repetitious &structure of the 
rest of the protein, the C-terminal polypeptide 
gives rise to a prediction for a predominately 
helical structure (fig.3b). It contains several 
charged groups (11 negative and 4 positive 
charges), is mainly hydrophilic in character and is 
predicted to be composed of two helices separated 
by a bend of coil or turn conformation. Interes- 
tingly, the 3 cDNA clones selected by immunoreac- 
tivity from the hgtll expression library all ter- 
minate in this region. As described elsewhere 
(Craft et al., submitted), although all 3 reacted 
with the monoclonal antibody MAbAl-GS, the 
product of the 420 bp fragment gave a markedly 
weaker reaction. This suggests that the boundary 
between the C-terminal ends of the 420 bp and 
150 bp fragment peptide products (fig.3b) is close 
to part of the antigenic site. Indeed, while the 
products of the 220 bp and 150 bp fragments are 
both predicted to contain the bend region and at 
least part of the final helix, the 420 bp product 
lacks all of the final helix. This implies that the 
epitope for the monoclonal antibody consists, at 
least in part, of the bend into the final helix. 
3.2. Inter-molecular comparisons 
Although the function of S-antigen in the visual 
system is not well understood, several pieces of 
evidence point to a possible relationship with 
purine nucleotide-binding proteins. Both S-antigen 
[4] and the GTP-binding protein transducin [21] 
interact with photoactivated rhodopsin. This leads 
respectively to the quenching or activation of the 
phosphodiesterase that mediates the light response 
in rod cells. Transducin has been shown to be 
closely related to the G-proteins of the adenylate 
cyclase system [22]. These proteins typically ex- 
hibit two different a-subunits, Ga, and Levi (both 
of -40 kDa), which have opposing stimulatory or 
inhibitory effects. The relationship between S- 
antigen and transducin in the activation/inactiva- 
tion of phosphodiesterase has interesting parallels 
with this system. 
In other work, a purine nucleotide (ATP)- 
binding activity has been proposed for an abun- 
dant retinal protein of similar size to S-antigen 
[23]. Furthermore, other workers have suggested 
that S-antigen is identical to one of the rhodopsin 
kinase activities of retina [24]. 
The predicted S-antigen amino-acid sequence 
was examined for homologies with the NBRF pro- 
tein sequence database but no large-scale 
similarities were detected using IDEAS [17] or the 
search programs of Wilbur and Lipman [25]. 
However, a detailed comparison with purine 
nucleotide-binding proteins revealed some in- 
teresting similarities, particularly with bovine (Y- 
transducin [26-281. Most interesting is the 
similarity between residues 206-226 of the S- 
antigen sequence and residues 326-350, the C- 
terminal 25 residues of ly-transducin [26-281 
(fig.3c). This part of a-transducin contains the 
proposed site for ADP-ribosylation by pertussis 
toxin [26-291 and this site in particular is more 
than 50% identical to the S-antigen sequence, with 
most non-identical residues conservatively varied 
(fig.3c). Since the modification of a-transducin by 
pertussis toxin [26-291 presumably occurs at a 
functionally important position [28,29], the 
similarity of the C-terminal region in S-antigen 
suggests the possibility of a functional relationship 
with cY-transducin. It also raises the interesting 
possibility of a role for toxin-mediated modifica- 
tion of S-antigen in uveitis. Furthermore, the 
replacement of Cys 347 with Ala 223 (fig.3c) may 
question the hypothesis that Cys 347 is the func- 
tionally active residue in the cu-transducin sequence 
and in equivalent positions in ras proteins [26-281. 
Elsewhere, residues 144-149 of S-antigen (Ser- 
Thr-Ile-Ile-Lys-Glu) are similar to residues 43-48 
of cu-transducin (Ser-Thr-Ile-Val-Lys-Gln) which 
are part of a 22-residue sequence of unknown 
function conserved between a-transducin and the 
a-subunits of brain GTP-binding proteins [30]. 
Purine nucleotide-binding proteins in general 
have other conserved functional sequences [3 1,321. 
The most characteristic of these is Gly-X-X-X-X- 
Gly-Lys at the phosphoryl binding site. Residues 
127-133 of the predicted S-antigen sequence have 
the sequence Gly-Be-Ala-Leu-Asp-Gly-Lys which 
fits this pattern. Another sequence, Asn-Lys-X- 
Asp is common to the guanine specificity regions 
of elongation factors, ras protein and a-transducin 
[32]. The closest matches to this sequence in S- 
antigen are Glu-Lys-Thr-Asp (229-232) and Asn- 
Leu-Lys-Asp (218-221). Another conserved se- 
quence of the purine nucleotide-binding site, Asp- 
X-X-Gly, with a preference for Ala or Pro at the 
third position [3 1,321, is not observed in the part of 
S-antigen for which data exist. 
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These similarities are consistent with the 
possibility that there is a functional relationship 
between S-antigen and w-transducin and perhaps 
with other members of the large and important 
family of purine nucleotide-binding proteins, 
although the relationship is much more distant 
than that between cu-transducin and ras proteins 
[26-281. The phosphoryl binding site similarities 
may relate to the binding of phosphorylated 
rhodopsin rather than a purine nucleotide but in 
view of the presence of S-antigen in the mam- 
malian pineal, where rhodopsin is absent [33], a 
more general function for S-antigen is possible. 
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